Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 16, 1998

View Archived Issues

Elan 'Replenishes Coffers' With US$750M Placement

New Cervical Smear Test Proves Superior In Studies

Celltech Says Data Positive In Pivotal Leukemia Study

OGS, Quintiles Team Up In Proteomics Agreement

Amrad Wins A$24.6M Grant For R&D From Government

Vaxis Aims For Share Of Impotence Market

Start-Up Wilex Targeting Tumor-Metastasis Enzymes

BioChem, SmithKline Sign Deal For Nasal Flu Vaccine

Teva Likely To Appeal Court's Fluoxetine Ruling

Vanguard Quits Dialysis Drug, Pairs With 3M For Hepatitis C

GPC, Byk Gulden Enter Deal For Genomic Targets

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...